Bornheimer J F, Kim J S, Sambasivan V, Biegler T L
Am Heart J. 1982 Dec;104(6):1288-93. doi: 10.1016/0002-8703(82)90158-2.
Resting, supine, and upright exercise hemodynamics were studied in 11 patients with pure or predominant mitral stenosis before and after 0.4 mg sublingual nitroglycerin. Resting mean pulmonary wedge pressure was reduced from 27 +/- 1.6 to 21 +/- 1.6 mm Hg (p less than 0.001), while mean cardiac index (2.98 +/- 0.40 vs 2.68 +/- 0.30 cc/min/m2; NS) and mean heart rate (82 +/- 4.4 vs 87 +/- 6.7 bpm; NS) were unchanged after nitroglycerin. Resting mean left ventricular end-diastolic pressure dropped from 11 +/- 1.7 to 8 +/- 1.1 mm Hg (p less than 0.02) after nitroglycerin, while stroke index (37 +/- 5.1 vs 32 +/- 3.8 mm Hg; NS) was unchanged. Left ventricular systolic pressure fell from 122 +/- 6.0 to 111 +/- 3.1 mm HG (p less than 0.001) after nitroglycerin. At peak supine exercise similar qualitative changes were observed. Mean pulmonary wedge pressure was lower after nitroglycerin (43 +/- 2.3 vs 36 +/- 2.1 mm Hg; p less than 0.02), while cardiac index (3.62 +/- 0.39 vs 3.4 +/- 0.26 cc/min/m2; NS) and heart rate (116 +/- 7.1 vs 113 +/- 4.6 bpm; NS) were not different. Left ventricular end-diastolic pressure (13 +/- 1.4 vs 10 +/- 1.3; NS) was slightly but not significantly reduced by nitroglycerin. Left ventricular stroke index (34 +/- 3.4 vs 31 +/- 2.2 mm Hg; NS) was unchanged by nitroglycerin. Left ventricular systolic pressure (137 +/- 7.3 vs 127 +/- 6.1 mm Hg; p less than 0.02) was reduced 10 mm Hg at peak supine exercise after nitroglycerin. During upright exercise, peak heart rate (160 +/- 8.1 vs 160 +/- 8.0 bpm; NS) and peak systolic blood pressure (117 +/- 5.7 vs 112 +/- 2.8 mm Hg; NS) were not changed with nitroglycerin. Exercise duration was improved after nitroglycerin (5.02 +/- 0.62 vs 5.66 +/- 0.65 minutes; p less than 0.02). Thus sublingual nitroglycerin lowers mean pulmonary wedge pressure to reduce pulmonary congestive symptoms, improves supine exercise hemodynamics, and may enhance treadmill exercise duration in some patients with pure or predominant mitral stenosis.
对11例单纯性或主要为二尖瓣狭窄的患者,在舌下含服0.4mg硝酸甘油前后,研究了静息、仰卧位及直立位运动时的血流动力学情况。静息时,平均肺楔压从27±1.6降至21±1.6mmHg(p<0.001),而硝酸甘油后平均心脏指数(2.98±0.40对2.68±0.30cc/min/m²;无显著性差异)和平均心率(82±4.4对87±6.7次/分钟;无显著性差异)未改变。硝酸甘油后静息时平均左心室舒张末期压力从11±1.7降至8±1.1mmHg(p<0.02),而每搏指数(37±5.1对32±3.8mmHg;无显著性差异)未改变。硝酸甘油后左心室收缩压从122±6.0降至111±3.1mmHg(p<0.001)。在仰卧位运动高峰时观察到类似的定性变化。硝酸甘油后平均肺楔压较低(43±2.3对36±2.1mmHg;p<0.02),而心脏指数(3.62±0.39对3.4±0.26cc/min/m²;无显著性差异)和心率(116±7.1对113±4.6次/分钟;无显著性差异)无差异。硝酸甘油使左心室舒张末期压力(13±1.4对10±1.3;无显著性差异)略有但无显著性降低。硝酸甘油对左心室每搏指数(34±3.4对31±2.2mmHg;无显著性差异)无影响。硝酸甘油后仰卧位运动高峰时左心室收缩压(137±7.3对127±6.1mmHg;p<0.02)降低10mmHg。在直立位运动期间,硝酸甘油对运动高峰心率(160±8.1对160±8.0次/分钟;无显著性差异)和运动高峰收缩压(117±5.7对112±2.8mmHg;无显著性差异)无影响。硝酸甘油后运动持续时间有所改善(5.02±0.62对5.66±0.65分钟;p<0.02)。因此,舌下含服硝酸甘油可降低平均肺楔压以减轻肺充血症状,改善仰卧位运动血流动力学,并可能增加某些单纯性或主要为二尖瓣狭窄患者的跑步机运动持续时间。